Kyobo 8 Special Purpose Acquisition Company (307280) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.063x

Based on the latest financial reports, Kyobo 8 Special Purpose Acquisition Company (307280) has a cash flow conversion efficiency ratio of 0.063x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.66 Billion ≈ $1.80 Million USD) by net assets (₩41.96 Billion ≈ $28.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Kyobo 8 Special Purpose Acquisition Comp share price for real-time trading data and today's change.

Kyobo 8 Special Purpose Acquisition Company - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 307280 company net worth for the company's overall valuation and market capitalisation.

Kyobo 8 Special Purpose Acquisition Company Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyobo 8 Special Purpose Acquisition Company ranked by their cash flow conversion efficiency. Also see 307280 total asset value for a full breakdown of the balance sheet.

Company Cash Flow Conversion Efficiency
Texxon Holding Ltd.
NASDAQ:NPT
N/A
Crown Crafts Inc
NASDAQ:CRWS
0.137x
RMG Acquisition Corp. III
NASDAQ:RMGCF
0.034x
5TH PLANET GAMES DK -50
F:2HG1
-0.027x
Colorpak Indonesia Tbk
JK:CLPI
0.041x
Live Ventures Inc
NASDAQ:LIVE
0.103x
Hotel Fitra International Tbk PT
JK:FITT
-0.096x
Atlas Pearls Ltd
AU:ATP
-0.048x

Annual Cash Flow Conversion Efficiency for Kyobo 8 Special Purpose Acquisition Company (2022–2025)

The table below shows the annual cash flow conversion efficiency of Kyobo 8 Special Purpose Acquisition Company from 2022 to 2025. Review 307280 free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩42.62 Billion
≈ $28.89 Million
₩8.48 Billion
≈ $5.75 Million
0.199x -16.18%
2024-12-31 ₩37.27 Billion
≈ $25.26 Million
₩8.85 Billion
≈ $6.00 Million
0.237x +60.22%
2023-12-31 ₩32.62 Billion
≈ $22.11 Million
₩4.84 Billion
≈ $3.28 Million
0.148x -31.24%
2022-12-31 ₩26.83 Billion
≈ $18.18 Million
₩5.78 Billion
≈ $3.92 Million
0.216x --

About Kyobo 8 Special Purpose Acquisition Company

KQ:307280 Korea Medical Instruments & Supplies
Market Cap
$28.61 Million
₩42.21 Billion KRW
Market Cap Rank
#24026 Global
#1677 in Korea
Share Price
₩6190.00
Change (1 day)
+0.00%
52-Week Range
₩5170.00 - ₩6380.00
All Time High
₩6380.00
About

Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more